Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

chauvin bausch & lomb, united kingdom - fluorescein sodium,lidocaine hydrochloride - eye drops, solution - 4,0.25 %,

Australia - English - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lignocaine hydrochloride; fluorescein sodium -

Ireland - English - HPRA (Health Products Regulatory Authority)

chauvin pharmaceuticals limited - fluorescein sodium - eye drops solution - 1 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

chauvin pharmaceuticals limited - fluorescein sodium - eye drops solution - 2.0 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

chauvin pharmaceuticals limited - lidocaine hydrochloride fluorescein sodium - eye drops solution - 4.0/0.25 % %w/v

United States - English - NLM (National Library of Medicine)

altaire pharmaceuticals inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir), benoxinate hydrochloride (unii: 0ve4u49k15) (benoxinate - unii:axq0jym303) - altafluor benox (fluorescein sodium and benoxinate hydrochloride ophthalmic solution) 0.25%/0.4% is indicated for ophthalmic procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent. altafluor benox is contraindicated in patients with known hypersensitivity to any component of this product. risk summary   there are no available data on the use of altafluor benox in pregnant women to inform any drug associated risk. adequate animal reproduction studies have not been conducted with fluorescein sodium and/or benoxinate hydrochloride. altafluor benox should be given to a pregnant woman only if clearly needed. risk summary    there are no data on the presence of fluorescein sodium or benoxinate hydrochloride in human milk after ocular administration of altafluor benox, the effects on the breastfed infant, or the effects on milk production. the developmental and health benefits of breastfeeding should be considered, along with the mother’s clinical need for altafluor benox a

United States - English - NLM (National Library of Medicine)

alcon, inc. - fluorescein sodium (unii: 93x55pe38x) (fluorescein - unii:tpy09g7xir) - fluorescite® injection 10% is indicated in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature. fluorescite® injection 10% is contraindicated in patients with known hypersensitivity to fluorescein sodium or any other ingredients in this product. rare cases of death due to anaphylaxis have been reported. [see warnings and precautions (5.1) and adverse reactions (6)]. fluorescein sodium can induce serious intolerance reactions. these reactions of intolerance are always unpredictable but they are more frequent in patients who have previously experienced an adverse reaction after fluorescein injection (symptoms other than nausea and vomiting) or in patients with history of allergy such as food or drug induced urticaria, asthma, eczema, allergic rhinitis. detailed questioning of each patient is recommended before the angiography to evaluate any prior history of allergy. adequate animal reproduction studies have not been conducted with fluorescein sodium.  it is also not known whether fluorescein sodium can cause fetal harm when administered to a pregnant woman. fluorescein sodium should be given to a pregnant woman only if clearly needed. fluorescein sodium injection has been demonstrated to be excreted in human milk for up to 4 days.  following fluorescein angiography, breast-feeding should therefore be discontinued for at least 4 days and the milk should be pumped off and discarded during this period. pediatric patients have been included in clinical studies.  no overall differences in safety or effectiveness have been observed between pediatric and adult patients. no overall differences in safety or effectiveness have been observed between elderly and other adult patients.

Namibia - English - Namibia Medicines Regulatory Council

soflens (pty) ltd - lignocaine, fluorescein - single dose eye drops - each 0,5 ml solution contains lignocaine hydrochloride 20,0 mg; fluorescein sodium 1,25 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

optimed pty ltd - 33737 - fluorescein strip - strips that are used to stain the eye for the fitting of contact lenses, diagnosis of corneal injury and applanation tonometry. they may also be used for the evaluation of dry eye.

Australia - English - Department of Health (Therapeutic Goods Administration)

carl zeiss pty ltd - 57883 - surgical microscope fluorescent angiography system - fluorescence guided surgery aids in viewing the visual assessment of intra-operative blood flow as well as vessel patency in surgical procedures in neurosurgery, plastic and reconstructive procedures and coronary artery bypass graft surgery.(this is not an invasive device)